{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T09:07:41Z","timestamp":1773392861729,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.suronc.2020.10.018","type":"journal-article","created":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T23:59:54Z","timestamp":1604275194000},"page":"533-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3635-695X","authenticated-orcid":false,"given":"Surya","family":"Ravichandran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0901-5554","authenticated-orcid":false,"given":"Neel","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-3054","authenticated-orcid":false,"given":"Gabriel","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-2272","authenticated-orcid":false,"given":"Visakha","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam K.","family":"Brys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brent A.","family":"Hanks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgia M.","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April K.S.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon A.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2020.10.018_bib1","author":"Melanoma Skin Cancer Statistics"},{"issue":"5","key":"10.1016\/j.suronc.2020.10.018_bib2","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.rcl.2013.06.004","article-title":"Positron emission tomography\/computed tomography in melanoma","volume":"51","author":"Bourgeois","year":"2013","journal-title":"Radiol. Clin."},{"issue":"4","key":"10.1016\/j.suronc.2020.10.018_bib3","first-page":"220","article-title":"Cancer treatment and survivorship statistics","volume":"62","author":"Siegel","year":"2012","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"4","key":"10.1016\/j.suronc.2020.10.018_bib4","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0733-8635(02)00037-2","article-title":"Melanoma incidence trends","volume":"20","author":"Bevona","year":"2002","journal-title":"Dermatol. Clin."},{"issue":"2","key":"10.1016\/j.suronc.2020.10.018_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.27616","article-title":"International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?","volume":"132","author":"Erdmann","year":"2012","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.suronc.2020.10.018_bib6","series-title":"AJCC Cancer Staging Handbook: from the AJCC Cancer Staging Manual","author":"Edge","year":"2010"},{"issue":"7","key":"10.1016\/j.suronc.2020.10.018_bib7","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1245\/s10434-007-9399-3","article-title":"Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy","volume":"14","author":"Gold","year":"2007","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2020.10.018_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/hed.23456","article-title":"No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma","author":"Bikhchandani","year":"2013","journal-title":"Head Neck"},{"issue":"2","key":"10.1016\/j.suronc.2020.10.018_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","article-title":"Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis","volume":"103","author":"Xing","year":"2010","journal-title":"JNCI J. National Cancer Institute"},{"issue":"1","key":"10.1016\/j.suronc.2020.10.018_bib10","doi-asserted-by":"crossref","DOI":"10.2217\/mmt-2019-0003","article-title":"Surveillance imaging for metastasis in high-risk melanoma: importance in individualized patient care and survivorship","volume":"6","author":"Freeman","year":"2019","journal-title":"Melanoma Management"},{"issue":"6","key":"10.1016\/j.suronc.2020.10.018_bib11","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2133.2011.10247.x","article-title":"Fluorodeoxyglucose positron emission tomography fails to detect distant metastases at initial staging of melanoma patients with metastatic involvement of sentinel lymph node","volume":"164","author":"Wagner","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.suronc.2020.10.018_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.suronc.2014.01.002","article-title":"Value of positron emission tomography scan in stage III cutaneous melanoma: a systematic review and meta-analysis","volume":"23","author":"Rivera","year":"2014","journal-title":"Surgical Oncology"},{"issue":"4","key":"10.1016\/j.suronc.2020.10.018_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1245\/ASO.2006.02.008","article-title":"Utility of preoperative [(18)]F fluorodeoxyglucose\u2013positron emission tomography scanning in high-risk melanoma patients","volume":"13","author":"Brady","year":"2006","journal-title":"Ann. Surg Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2020.10.018_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/CMR.0b013e3283480256","article-title":"The role of positron emission tomography with computed tomography in the follow-up of asymptomatic cutaneous malignant melanoma patients with a high risk of disease recurrence","volume":"21","author":"Abbott","year":"2011","journal-title":"Melanoma Res."},{"issue":"8","key":"10.1016\/j.suronc.2020.10.018_bib15","first-page":"1323","article-title":"Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?","volume":"45","author":"Fuster","year":"2004","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.suronc.2020.10.018_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/2046-4053-1-62","article-title":"F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET\/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review","volume":"1","author":"Schr\u00f6er-G\u00fcnther","year":"2012","journal-title":"Syst. Rev."},{"issue":"2","key":"10.1016\/j.suronc.2020.10.018_bib17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejca.2009.10.032","article-title":"Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline","volume":"46","author":"Garbe","year":"2010","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.suronc.2020.10.018_bib18","doi-asserted-by":"crossref","first-page":"iv129","DOI":"10.1093\/annonc\/mdp152","article-title":"Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Dummer","year":"2009","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2020.10.018_bib19","first-page":"325","article-title":"Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French Standards, Options and Recommendations guidelines. Summary report","volume":"17","author":"Saiag","year":"2007","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.suronc.2020.10.018_bib20","author":"NCCN Guidelines for Patients"},{"key":"10.1016\/j.suronc.2020.10.018_bib21","doi-asserted-by":"crossref","first-page":"v126","DOI":"10.1093\/annonc\/mdv297","article-title":"Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Dummer","year":"2015","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2020.10.018_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/1754-9485.12173","article-title":"FDG PET in early stage cutaneous malignant melanoma","volume":"58","author":"McIvor","year":"2014","journal-title":"J. Med. Imag. Rad. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2020.10.018_bib23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/archsurg.141.3.284","article-title":"Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma","volume":"141","author":"Clark","year":"2006","journal-title":"Arch. Surg."},{"issue":"4","key":"10.1016\/j.suronc.2020.10.018_bib24","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.0007-0963.2004.05870.x","article-title":"Baseline staging in cutaneous malignant melanoma","volume":"150","author":"Hafner","year":"2004","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.suronc.2020.10.018_bib25","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cncr.21189","article-title":"Inefficacy of F\u201018 fluorodeoxy\u2010D\u2010glucose\u2010positron emission tomography scans for initial evaluation in early\u2010stage cutaneous melanoma","volume":"104","author":"Wagner","year":"2005","journal-title":"Cancer: Interdisciplinary Int. J. Am. Canc. Soc."},{"issue":"8","key":"10.1016\/j.suronc.2020.10.018_bib26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0748-7983(03)00147-1","article-title":"Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma","volume":"29","author":"Havenga","year":"2003","journal-title":"Eur. J. Surg. Oncol."},{"issue":"18","key":"10.1016\/j.suronc.2020.10.018_bib27","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1200\/JCO.2006.05.6176","article-title":"Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node\u2013positive melanoma","volume":"24","author":"Aloia","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.suronc.2020.10.018_bib28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archsurg.139.8.831","article-title":"Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease","volume":"139","author":"Miranda","year":"2004","journal-title":"Arch. Surg."},{"key":"10.1016\/j.suronc.2020.10.018_bib29","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1245\/s10434-012-2475-3","article-title":"Sentinel lymph node biopsy for melanoma: American society of clinical oncology and society of surgical oncology Joint clinical practice guideline","volume":"19","author":"Wong","year":"2012","journal-title":"Ann. Surg Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2020.10.018_bib30","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1002\/cncr.22320","article-title":"Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma","volume":"107","author":"Gannon","year":"2006","journal-title":"Cancer: Interdisciplinary Int. J. Am. Canc. Soc."},{"key":"10.1016\/j.suronc.2020.10.018_bib31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10434-000-0469-z","article-title":"Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience","volume":"7","author":"Cascinelli","year":"2000","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2020.10.018_bib32","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1002\/1097-0142(20010615)91:12<2401::AID-CNCR1274>3.0.CO;2-I","article-title":"The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma","volume":"91","author":"Statius Muller","year":"2001","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.suronc.2020.10.018_bib33","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jacr.2008.02.022","article-title":"PET vs sentinel lymph node biopsy for staging melanoma: a patient intervention, comparison, outcome analysis","volume":"5","author":"El-Maraghi","year":"2008","journal-title":"J. Am. Coll. Radiol."},{"issue":"1","key":"10.1016\/j.suronc.2020.10.018_bib34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11307-006-0065-0","article-title":"2-Deoxy-2-[F-18]fluoro-d-glucose positron emission tomography\/computed tomography in the management of melanoma","volume":"9","author":"Iagaru","year":"2006","journal-title":"Mol. Imag. Biol."},{"issue":"5","key":"10.1016\/j.suronc.2020.10.018_bib35","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/cncr.22868","article-title":"Role of radiologic imaging at the time of initial diagnosis of stage T1b-T3b melanoma","volume":"110","author":"Yancovitz","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.suronc.2020.10.018_bib36","doi-asserted-by":"crossref","first-page":"281","DOI":"10.6004\/jnccn.2009.0021","article-title":"Review of evidence-based support for pretreatment imaging in melanoma","volume":"7","author":"Sabel","year":"2009","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"17","key":"10.1016\/j.suronc.2020.10.018_bib37","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1001\/jama.2012.476","article-title":"Choosing wisely","volume":"307","author":"Cassel","year":"2012","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.suronc.2020.10.018_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/CMR.0b013e32830b363b","article-title":"Preoperative 18F-FDG-PET\/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma","volume":"18","author":"Singh","year":"2008","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.suronc.2020.10.018_bib39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.2003.01.091","article-title":"Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy","volume":"21","author":"Garbe","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2020.10.018_bib40","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaad.2016.02.1229","article-title":"Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: a prospective cohort study","volume":"75","author":"Podlipnik","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.suronc.2020.10.018_bib41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1245\/s10434-017-5768-8","article-title":"Routine computer tomography imaging for the detection of recurrences in high-risk melanoma patients","volume":"24","author":"Park","year":"2017","journal-title":"Ann. Surg Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2020.10.018_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000317","article-title":"Contemporary outcomes from the use of regular imaging to detect relapse in high-risk cutaneous melanoma","volume":"3","author":"Lim","year":"2018","journal-title":"ESMO Open"},{"issue":"7","key":"10.1016\/j.suronc.2020.10.018_bib43","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/annonc\/mdy124","article-title":"Surveillance imaging with FDG-PET\/CT in the post-operative follow-up of stage 3 melanoma","volume":"29","author":"Lewin","year":"2018","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.suronc.2020.10.018_bib44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.ejca.2015.01.007","article-title":"Prospective evaluation of follow-up in melanoma patients in Germany \u2013 results of a multicentre and longitudinal study","volume":"51","author":"Livingstone","year":"2015","journal-title":"Eur. J. Canc."},{"issue":"4","key":"10.1016\/j.suronc.2020.10.018_bib45","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/CMR.0000000000000344","article-title":"Association between the use of surveillance PET\/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma","volume":"27","author":"Leon-Ferre","year":"2017","journal-title":"Melanoma Res."},{"key":"10.1016\/j.suronc.2020.10.018_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/S0959-8049(17)30496-3","article-title":"PET\/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study","volume":"72","author":"Madu","year":"2017","journal-title":"Eur. J. Canc."},{"issue":"4","key":"10.1016\/j.suronc.2020.10.018_bib47","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jamcollsurg.2016.12.038","article-title":"Patient symptoms are the most frequent indicators of recurrence in patients with American Joint committee on cancer stage II melanoma","volume":"224","author":"Berger","year":"2017","journal-title":"J. Am. Coll. Surg."},{"issue":"36","key":"10.1016\/j.suronc.2020.10.018_bib48","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.suronc.2020.10.018_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/RLU.0000000000001275","article-title":"18F-FDG PET\/CT and melanoma","volume":"41","author":"Mena","year":"2016","journal-title":"Clin. Nucl. Med."},{"issue":"2","key":"10.1016\/j.suronc.2020.10.018_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/biom8020021","article-title":"Circulating MicroRNA biomarkers in melanoma: tools and challenges in personalised medicine","volume":"8","author":"Mumford","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.suronc.2020.10.018_bib51","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/0959-8049(95)00087-9","article-title":"Clinical significant of serum S100 in metastatic malignant melanoma","volume":"31","author":"Guo","year":"1995","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.suronc.2020.10.018_bib52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00008390-199604000-00008","article-title":"Prognostic value of serum analyses of S100-B protein in malignant melanoma","volume":"6","author":"Von Schoultz","year":"1996","journal-title":"Melanoma Res."},{"issue":"3","key":"10.1016\/j.suronc.2020.10.018_bib53","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41416-018-0167-x","article-title":"S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies","volume":"119","author":"Wagner","year":"2018","journal-title":"Br. J. Canc."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740420304266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740420304266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:23:05Z","timestamp":1760757785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740420304266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":53,"alternative-id":["S0960740420304266"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2020.10.018","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2020.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}